IL37 and neoplasm: B6 mice were s.c. inoculated with tumor cells B16 or LLC in the right flank, and the resulting tumor-bearing mice were i.t. injected with PBS, vvDD, or vvDD-IL-23 at day 10 or day 7 after tumor cell inoculation, respectively.